Free Trial

Dorman Products (DORM) Financials

Dorman Products logo
$114.39 +0.19 (+0.17%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$113.00 -1.39 (-1.22%)
As of 04/25/2025 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Dorman Products

Annual Income Statements for Dorman Products

This table shows Dorman Products' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
92 106 107 134 84 107 130 120 130 186
Consolidated Net Income / (Loss)
92 106 107 134 84 107 132 122 129 190
Net Income / (Loss) Continuing Operations
92 106 107 134 84 107 132 122 129 190
Total Pre-Tax Income
146 168 177 171 106 136 170 156 169 256
Total Operating Income
146 169 176 171 106 133 172 171 215 293
Total Gross Profit
308 338 359 373 340 383 463 564 685 806
Total Revenue
803 860 903 974 991 1,093 1,345 1,734 1,930 2,009
Operating Revenue
803 860 903 974 991 1,093 1,345 1,734 1,930 2,009
Total Cost of Revenue
495 522 545 600 652 710 882 1,169 1,244 1,203
Operating Cost of Revenue
495 522 545 600 652 710 882 1,169 1,244 1,203
Total Operating Expenses
162 169 182 202 234 250 291 393 471 513
Selling, General & Admin Expense
162 169 182 202 234 250 291 393 471 513
Total Other Income / (Expense), net
-0.22 -0.24 0.35 -0.01 -0.02 2.36 -1.79 -15 -46 -37
Interest Expense
- - - - 0.23 0.60 2.16 16 48 40
Other Income / (Expense), net
-0.22 -0.24 0.35 -0.01 0.21 2.96 0.38 0.74 1.80 3.07
Income Tax Expense
54 62 70 38 22 29 38 35 39 66
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
- - - - 0.00 - 1.44 1.86 -0.71 4.19
Basic Earnings per Share
$2.60 $3.07 $3.14 $4.04 $2.57 $3.31 $4.13 $3.87 $4.11 $6.17
Weighted Average Basic Shares Outstanding
35.47M 34.52M 33.96M 33.10M 32.61M 32.28M 31.81M 31.43M 31.46M 30.80M
Diluted Earnings per Share
$2.60 $3.07 $3.13 $4.02 $2.56 $3.30 $4.12 $3.85 $4.10 $6.14
Weighted Average Diluted Shares Outstanding
35.54M 34.60M 34.05M 33.21M 32.69M 32.37M 31.96M 31.54M 31.53M 30.96M
Weighted Average Basic & Diluted Shares Outstanding
35.50M 34.50M 33.90M 33.10M 32.55M 32.18M 31.55M 31.45M 31.09M 30.58M

Quarterly Income Statements for Dorman Products

This table shows Dorman Products' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
28 18 5.80 33 39 52 32 47 56 51
Consolidated Net Income / (Loss)
31 18 5.68 33 41 50 33 47 55 55
Net Income / (Loss) Continuing Operations
31 18 5.68 33 41 50 33 47 55 55
Total Pre-Tax Income
40 23 6.52 43 53 66 44 62 71 79
Total Operating Income
42 33 18 55 64 77 54 72 79 87
Total Gross Profit
132 158 144 164 183 194 181 199 204 222
Total Revenue
413 501 467 481 488 494 469 503 504 534
Operating Revenue
413 501 467 481 488 494 469 503 504 534
Total Cost of Revenue
282 344 322 317 305 300 287 304 300 312
Operating Cost of Revenue
282 344 322 317 305 300 287 304 300 312
Total Operating Expenses
90 125 126 108 119 117 127 127 125 135
Selling, General & Admin Expense
90 125 126 108 119 117 127 127 125 135
Total Other Income / (Expense), net
-2.41 -9.84 -12 -12 -12 -11 -11 -10 -8.15 -7.80
Interest Expense
2.34 10 12 13 12 11 11 10 9.76 9.16
Other Income / (Expense), net
-0.07 0.61 0.36 0.40 0.61 0.45 -0.04 0.14 1.62 1.36
Income Tax Expense
9.09 5.10 0.84 10 12 16 11 15 16 24
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
2.11 - -0.12 -0.57 1.21 -1.24 1.10 0.52 -0.65 3.22
Basic Earnings per Share
$0.97 $0.57 $0.18 $1.04 $1.29 $1.60 $1.05 $1.53 $1.81 $1.78
Weighted Average Basic Shares Outstanding
31.41M 31.43M 31.44M 31.47M 31.48M 31.46M 31.14M 30.96M 30.57M 30.80M
Diluted Earnings per Share
$0.97 $0.57 $0.18 $1.04 $1.28 $1.60 $1.05 $1.53 $1.80 $1.76
Weighted Average Diluted Shares Outstanding
31.55M 31.54M 31.54M 31.53M 31.56M 31.53M 31.25M 31.07M 30.74M 30.96M
Weighted Average Basic & Diluted Shares Outstanding
31.42M 31.45M 31.47M 31.49M 31.49M 31.09M 31.01M 30.57M 30.52M 30.58M

Annual Cash Flow Statements for Dorman Products

This table details how cash moves in and out of Dorman Products' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
31 70 -77 -28 25 87 -97 -13 -9.22 20
Net Cash From Operating Activities
92 122 94 78 95 152 100 42 209 231
Net Cash From Continuing Operating Activities
92 122 94 78 95 152 100 42 209 231
Net Income / (Loss) Continuing Operations
92 106 107 134 84 107 132 122 129 190
Consolidated Net Income / (Loss)
92 106 107 134 84 107 132 122 129 190
Depreciation Expense
16 19 22 28 26 32 35 45 55 57
Non-Cash Adjustments To Reconcile Net Income
4.14 3.60 3.46 2.89 3.12 55 5.99 9.34 16 15
Changes in Operating Assets and Liabilities, net
-21 -7.02 -38 -87 -17 -42 -72 -134 8.69 -31
Net Cash From Investing Activities
-24 -26 -94 -59 -30 -30 -365 -527 -44 -39
Net Cash From Continuing Investing Activities
-24 -26 -94 -59 -30 -30 -365 -527 -44 -39
Purchase of Property, Plant & Equipment
-22 -20 -24 -26 -30 -15 -20 -38 -44 -39
Acquisitions
0.00 0.00 -60 -28 0.00 -15 -345 -489 0.07 0.10
Net Cash From Financing Activities
-37 -25 -77 -47 -41 -34 168 472 -174 -171
Net Cash From Continuing Financing Activities
-37 -25 -77 -47 -41 -34 168 472 -174 -171
Repayment of Debt
- - - 0.00 0.00 -99 -17 -17 -159 -94
Repurchase of Common Equity
- -25 -76 -45 -41 - -63 -20 -16 -81
Issuance of Debt
- - - 0.00 0.00 99 252 510 0.00 0.00
Other Financing Activities, net
-37 -0.15 -1.14 -1.59 0.49 -34 -4.26 -0.53 0.70 4.46
Other Net Changes in Cash
- - - - 0.00 0.00 -0.04 -0.09 0.03 -0.42
Cash Interest Paid
0.28 0.27 0.29 0.25 0.34 0.75 1.78 12 50 39
Cash Income Taxes Paid
57 62 75 30 29 28 46 63 35 57

Quarterly Cash Flow Statements for Dorman Products

This table details how cash moves in and out of Dorman Products' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-17 11 -13 2.36 -3.71 4.86 -2.38 13 -2.34 12
Net Cash From Operating Activities
-8.04 12 26 67 56 60 52 63 44 71
Net Cash From Continuing Operating Activities
-8.04 12 26 67 56 60 52 63 44 71
Net Income / (Loss) Continuing Operations
31 18 5.68 33 41 50 33 47 55 55
Consolidated Net Income / (Loss)
31 18 5.68 33 41 50 33 47 55 55
Depreciation Expense
12 14 14 13 14 14 14 14 15 14
Non-Cash Adjustments To Reconcile Net Income
14 -9.20 5.08 2.71 3.34 4.95 2.94 3.82 3.86 4.48
Changes in Operating Assets and Liabilities, net
-64 -9.84 1.91 18 -1.45 -9.53 2.36 -2.24 -30 -1.25
Net Cash From Investing Activities
-7.68 -504 -10 -13 -9.67 -11 -11 -12 -8.56 -8.08
Net Cash From Continuing Investing Activities
-7.68 -504 -10 -13 -9.67 -11 -11 -12 -8.56 -8.08
Purchase of Property, Plant & Equipment
-7.68 -14 -11 -13 -9.67 -11 -11 -12 -8.56 -8.18
Acquisitions
- -490 0.27 -0.20 - - 0.00 - - 0.10
Net Cash From Financing Activities
-0.72 502 -29 -51 -50 -44 -44 -38 -38 -51
Net Cash From Continuing Financing Activities
-0.72 502 -29 -51 -50 -44 -44 -38 -38 -51
Repayment of Debt
- -7.04 -27 -52 -50 -30 -15 -15 -11 -54
Repurchase of Common Equity
- - -0.43 -0.40 -0.18 -15 -28 -24 -28 -0.89
Other Financing Activities, net
-0.72 19 -1.21 0.99 -0.01 0.92 -1.23 0.89 0.61 4.19
Other Net Changes in Cash
- 0.00 -0.00 0.04 -0.06 0.05 -0.04 -0.02 0.03 -0.39
Cash Interest Paid
2.08 7.28 12 15 12 11 10 9.94 6.53 12
Cash Income Taxes Paid
13 13 1.06 14 12 8.22 0.84 26 13 17

Annual Balance Sheets for Dorman Products

This table presents Dorman Products' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
622 712 766 978 1,041 1,221 1,673 2,342 2,292 2,425
Total Current Assets
479 552 533 720 755 923 1,077 1,269 1,234 1,370
Cash & Equivalents
79 149 72 43 68 156 59 46 37 57
Accounts Receivable
204 231 242 401 392 461 473 427 527 574
Inventories, net
194 169 212 271 281 299 532 756 637 708
Prepaid Expenses
2.33 3.12 7.13 5.65 14 7.76 13 40 33 31
Plant, Property, & Equipment, net
87 88 93 99 102 91 115 148 160 164
Total Noncurrent Assets
56 72 140 159 185 207 482 924 899 890
Goodwill
30 28 66 73 74 91 197 443 444 443
Intangible Assets
- 1.64 22 25 21 25 179 322 302 278
Noncurrent Deferred & Refundable Income Taxes
7.56 12 7.88 6.23 4.34 12 - - 0.00 5.79
Other Noncurrent Operating Assets
19 30 44 55 85 78 106 159 153 163
Total Liabilities & Shareholders' Equity
622 712 766 978 1,041 1,221 1,673 2,342 2,292 2,425
Total Liabilities
104 110 131 250 267 367 740 1,299 1,124 1,131
Total Current Liabilities
99 104 111 232 221 323 665 678 547 564
Short-Term Debt
- - - - - 0.00 239 252 108 42
Accounts Payable
64 73 80 109 90 118 177 180 177 232
Accrued Expenses
24 19 18 109 120 185 222 227 238 246
Current Employee Benefit Liabilities
11 12 12 15 9.78 20 27 19 24 44
Total Noncurrent Liabilities
5.26 6.30 20 18 47 44 75 621 577 567
Long-Term Debt
- - - - - - - 482 467 440
Capital Lease Obligations
- - - 0.00 30 37 - 98 91 105
Noncurrent Deferred & Payable Income Tax Liabilities
- 0.00 6.60 4.79 3.96 3.82 18 12 8.93 3.70
Other Noncurrent Operating Liabilities
5.26 6.30 14 14 13 3.56 57 28 9.63 19
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
518 602 635 728 774 854 933 1,043 1,168 1,293
Total Preferred & Common Equity
518 602 635 728 774 854 933 1,043 1,168 1,293
Total Common Equity
518 602 635 728 774 854 933 1,043 1,168 1,293
Common Stock
43 45 45 48 53 64 78 89 101 119
Retained Earnings
475 557 590 679 721 789 856 957 1,069 1,181
Accumulated Other Comprehensive Income / (Loss)
- - - - - 0.00 -1.44 -3.30 -2.59 -6.78

Quarterly Balance Sheets for Dorman Products

This table presents Dorman Products' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,801 2,261 2,257 2,260 2,220 2,286 2,364
Total Current Assets
1,177 1,190 1,189 1,195 1,163 1,233 1,316
Cash & Equivalents
35 33 36 32 34 47 45
Accounts Receivable
433 429 453 484 486 526 571
Inventories, net
678 687 643 626 620 620 665
Prepaid Expenses
30 40 58 53 22 39 35
Plant, Property, & Equipment, net
122 152 157 158 162 166 166
Total Noncurrent Assets
502 919 912 907 895 887 882
Goodwill
196 443 444 443 443 443 443
Intangible Assets
169 317 313 307 296 290 284
Other Noncurrent Operating Assets
137 159 155 157 156 154 155
Total Liabilities & Shareholders' Equity
1,801 2,261 2,257 2,260 2,220 2,286 2,364
Total Liabilities
780 1,212 1,171 1,132 1,046 1,084 1,129
Total Current Liabilities
674 607 570 533 466 514 561
Short-Term Debt
229 228 179 132 94 85 81
Accounts Payable
199 146 152 158 131 165 206
Accrued Expenses
230 219 224 227 222 242 248
Current Employee Benefit Liabilities
16 15 15 16 18 22 27
Total Noncurrent Liabilities
106 605 600 599 580 570 568
Long-Term Debt
- 479 476 473 467 461 455
Capital Lease Obligations
84 97 93 95 93 90 94
Noncurrent Deferred & Payable Income Tax Liabilities
17 12 15 15 9.35 9.32 9.64
Other Noncurrent Operating Liabilities
5.16 17 16 15 10 10 9.20
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,021 1,049 1,086 1,128 1,174 1,201 1,235
Total Preferred & Common Equity
1,021 1,049 1,086 1,128 1,174 1,201 1,235
Total Common Equity
1,021 1,049 1,086 1,128 1,174 1,201 1,235
Common Stock
86 91 95 98 103 107 111
Retained Earnings
939 962 994 1,034 1,076 1,099 1,127
Accumulated Other Comprehensive Income / (Loss)
-3.86 -3.18 -2.62 -3.83 -3.69 -4.21 -3.56

Annual Metrics and Ratios for Dorman Products

This table displays calculated financial ratios and metrics derived from Dorman Products' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
6.85% 7.05% 5.07% 7.80% 1.81% 10.23% 23.11% 28.88% 11.31% 4.11%
EBITDA Growth
5.69% 15.51% 6.17% 0.36% -33.87% 27.80% 22.82% 4.51% 25.33% 30.00%
EBIT Growth
3.70% 15.36% 4.89% -3.09% -38.04% 28.57% 26.11% -0.08% 26.07% 36.67%
NOPAT Growth
2.61% 14.85% 0.18% 25.58% -37.30% 25.34% 26.57% 0.14% 23.77% 31.83%
Net Income Growth
2.60% 14.86% 0.52% 25.33% -37.30% 27.59% 23.08% -7.59% 6.34% 46.99%
EPS Growth
4.42% 18.08% 1.95% 28.43% -36.32% 28.91% 24.85% -6.55% 6.49% 49.76%
Operating Cash Flow Growth
54.36% 32.02% -22.46% -17.11% 22.01% 59.45% -33.97% -58.45% 400.76% 10.68%
Free Cash Flow Firm Growth
134.67% 37.87% -104.52% 398.60% 162.62% 218.06% -333.86% -137.53% 133.57% -1.65%
Invested Capital Growth
6.03% 2.99% 24.44% 21.50% 7.42% 0.01% 51.46% 64.30% -1.69% 1.38%
Revenue Q/Q Growth
4.00% 2.90% -0.15% 3.47% -2.05% 5.98% 7.77% 6.32% -0.36% 2.00%
EBITDA Q/Q Growth
4.07% 7.46% -1.02% 1.80% -16.53% 21.06% -0.41% -3.77% 19.73% 2.97%
EBIT Q/Q Growth
3.95% 7.98% -1.83% 0.62% -17.39% 21.88% -0.78% -6.41% 25.72% 3.65%
NOPAT Q/Q Growth
3.52% 6.96% -5.91% 10.55% -17.03% 21.09% -0.68% -6.68% 24.99% 0.51%
Net Income Q/Q Growth
3.51% 6.97% -5.94% 10.44% -16.91% 20.80% -1.40% -11.79% 33.52% 2.28%
EPS Q/Q Growth
3.59% 7.72% -5.72% 10.44% -16.07% 20.88% -0.96% -11.49% 33.55% 2.68%
Operating Cash Flow Q/Q Growth
32.05% 34.92% -24.84% -21.96% 31.37% -16.21% 19.67% -19.96% 29.30% 5.37%
Free Cash Flow Firm Q/Q Growth
53.22% 50.05% -104.90% 175.32% 157,210.24% -25.73% 23.34% -8,022.42% 153.43% -0.65%
Invested Capital Q/Q Growth
-1.65% -6.51% 10.13% 5.44% -1.98% 5.72% -3.12% 40.82% 0.08% 0.21%
Profitability Metrics
- - - - - - - - - -
Gross Margin
38.36% 39.33% 39.71% 38.34% 34.28% 35.06% 34.41% 32.56% 35.52% 40.13%
EBITDA Margin
20.19% 21.79% 22.01% 20.49% 13.31% 15.43% 15.40% 12.49% 14.06% 17.55%
Operating Margin
18.20% 19.61% 19.51% 17.58% 10.68% 12.21% 12.75% 9.87% 11.13% 14.58%
EBIT Margin
18.18% 19.59% 19.55% 17.58% 10.70% 12.48% 12.78% 9.91% 11.22% 14.73%
Profit (Net Income) Margin
11.50% 12.34% 11.80% 13.72% 8.45% 9.78% 9.78% 7.01% 6.70% 9.46%
Tax Burden Percent
63.26% 62.99% 60.37% 78.07% 79.16% 78.73% 77.48% 77.82% 76.71% 74.15%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 99.78% 99.56% 98.74% 90.93% 77.81% 86.58%
Effective Tax Rate
36.74% 37.01% 39.63% 21.93% 20.84% 21.27% 22.52% 22.18% 23.29% 25.85%
Return on Invested Capital (ROIC)
21.66% 23.81% 20.95% 21.42% 11.81% 14.29% 14.38% 9.05% 9.08% 11.99%
ROIC Less NNEP Spread (ROIC-NNEP)
21.88% 23.95% 20.76% 21.43% 11.85% 11.92% 9.93% 6.66% 4.07% 7.31%
Return on Net Nonoperating Assets (RNNOA)
-2.82% -4.87% -3.71% -1.81% -0.65% -1.15% 0.35% 3.26% 2.61% 3.44%
Return on Equity (ROE)
18.84% 18.94% 17.24% 19.61% 11.16% 13.14% 14.73% 12.31% 11.69% 15.44%
Cash Return on Invested Capital (CROIC)
15.81% 20.87% -0.83% 2.01% 4.65% 14.27% -26.55% -39.61% 10.79% 10.63%
Operating Return on Assets (OROA)
24.74% 25.25% 23.90% 19.63% 10.50% 12.06% 11.88% 8.56% 9.35% 12.55%
Return on Assets (ROA)
15.65% 15.90% 14.43% 15.32% 8.30% 9.45% 9.09% 6.05% 5.58% 8.06%
Return on Common Equity (ROCE)
18.84% 18.94% 17.24% 19.61% 11.16% 13.14% 14.73% 12.31% 11.69% 15.44%
Return on Equity Simple (ROE_SIMPLE)
17.82% 17.63% 16.79% 18.36% 10.83% 12.52% 14.10% 11.66% 11.06% 14.69%
Net Operating Profit after Tax (NOPAT)
92 106 106 134 84 105 133 133 165 217
NOPAT Margin
11.52% 12.35% 11.78% 13.72% 8.45% 9.61% 9.88% 7.68% 8.54% 10.81%
Net Nonoperating Expense Percent (NNEP)
-0.22% -0.13% 0.19% -0.01% -0.04% 2.37% 4.46% 2.39% 5.01% 4.69%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 7.10% 8.98% 11.55%
Cost of Revenue to Revenue
61.64% 60.67% 60.29% 61.66% 65.72% 64.94% 65.59% 67.44% 64.48% 59.87%
SG&A Expenses to Revenue
20.16% 19.72% 20.20% 20.76% 23.60% 22.85% 21.66% 22.69% 24.39% 25.56%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
20.16% 19.72% 20.20% 20.76% 23.60% 22.85% 21.66% 22.69% 24.39% 25.56%
Earnings before Interest and Taxes (EBIT)
146 168 177 171 106 136 172 172 217 296
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
162 187 199 200 132 169 207 216 271 353
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.36 4.20 3.25 4.01 3.18 3.39 3.61 2.44 2.25 3.06
Price to Tangible Book Value (P/TBV)
3.57 4.42 3.77 4.64 3.63 3.92 6.05 9.17 6.21 6.91
Price to Revenue (P/Rev)
2.17 2.94 2.28 3.00 2.48 2.65 2.50 1.47 1.36 1.97
Price to Earnings (P/E)
18.87 23.85 19.34 21.85 29.39 27.06 25.87 21.23 20.21 21.28
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.30% 4.19% 5.17% 4.58% 3.40% 3.70% 3.87% 4.71% 4.95% 4.70%
Enterprise Value to Invested Capital (EV/IC)
3.79 5.26 3.53 4.20 3.30 3.77 3.19 1.82 1.81 2.46
Enterprise Value to Revenue (EV/Rev)
2.07 2.77 2.20 2.95 2.44 2.54 2.64 1.92 1.69 2.23
Enterprise Value to EBITDA (EV/EBITDA)
10.26 12.71 10.01 14.42 18.37 16.44 17.12 15.37 12.00 12.71
Enterprise Value to EBIT (EV/EBIT)
11.40 14.13 11.27 16.81 22.85 20.34 20.62 19.37 15.04 15.15
Enterprise Value to NOPAT (EV/NOPAT)
17.99 22.41 18.71 21.53 28.93 26.41 26.68 25.00 19.77 20.64
Enterprise Value to Operating Cash Flow (EV/OCF)
18.07 19.58 21.12 36.82 25.43 18.25 35.34 79.82 15.60 19.40
Enterprise Value to Free Cash Flow (EV/FCFF)
24.65 25.57 0.00 229.01 73.47 26.43 0.00 0.00 16.65 23.30
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.04 0.04 0.26 0.80 0.57 0.45
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.04 0.04 0.00 0.56 0.48 0.42
Financial Leverage
-0.13 -0.20 -0.18 -0.08 -0.05 -0.10 0.03 0.49 0.64 0.47
Leverage Ratio
1.20 1.19 1.20 1.28 1.35 1.39 1.62 2.03 2.10 1.92
Compound Leverage Factor
1.20 1.19 1.20 1.28 1.34 1.38 1.60 1.85 1.63 1.66
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 3.70% 4.16% 20.42% 44.40% 36.34% 31.21%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.42% 13.43% 5.91% 2.24%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 3.70% 4.16% 0.00% 30.97% 30.43% 28.97%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 96.30% 95.84% 79.58% 55.60% 63.66% 68.79%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.23 0.22 1.16 3.85 2.46 1.66
Net Debt to EBITDA
0.00 0.00 0.00 0.00 -0.29 -0.70 0.87 3.63 2.32 1.50
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.23 0.22 0.00 2.68 2.06 1.54
Debt to NOPAT
0.00 0.00 0.00 0.00 0.35 0.35 1.80 6.25 4.05 2.70
Net Debt to NOPAT
0.00 0.00 0.00 0.00 -0.46 -1.13 1.36 5.91 3.82 2.44
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.35 0.35 0.00 4.36 3.39 2.51
Altman Z-Score
13.94 17.61 13.11 10.14 8.40 7.49 4.88 3.03 3.57 4.41
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.86 5.31 4.81 3.10 3.42 2.86 1.62 1.87 2.25 2.43
Quick Ratio
2.87 3.66 2.83 1.91 2.09 1.91 0.80 0.70 1.03 1.12
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
67 93 -4.21 13 33 105 -245 -583 196 192
Operating Cash Flow to CapEx
424.47% 605.91% 385.44% 299.21% 322.42% 983.60% 505.74% 110.04% 474.80% 586.10%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 142.78 175.13 -113.48 -37.40 4.07 4.84
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 412.58 253.70 46.41 2.68 4.34 5.82
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 284.61 227.91 37.23 0.24 3.43 4.82
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.36 1.29 1.22 1.12 0.98 0.97 0.93 0.86 0.83 0.85
Accounts Receivable Turnover
3.92 3.96 3.82 3.03 2.50 2.56 2.88 3.85 4.04 3.65
Inventory Turnover
2.70 2.88 2.86 2.49 2.36 2.45 2.12 1.82 1.79 1.79
Fixed Asset Turnover
9.48 9.80 9.97 10.18 9.89 11.33 13.07 13.17 12.51 12.38
Accounts Payable Turnover
8.01 7.64 7.13 6.34 6.53 6.81 5.98 6.55 6.98 5.89
Days Sales Outstanding (DSO)
93.18 92.24 95.45 120.43 145.89 142.41 126.66 94.75 90.24 99.97
Days Inventory Outstanding (DIO)
135.43 126.88 127.68 146.70 154.44 149.04 171.82 201.01 204.34 204.12
Days Payable Outstanding (DPO)
45.54 47.80 51.22 57.54 55.89 53.57 61.07 55.75 52.28 61.98
Cash Conversion Cycle (CCC)
183.06 171.31 171.91 209.59 244.43 237.88 237.41 240.01 242.30 242.12
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
439 453 563 684 735 735 1,113 1,829 1,798 1,823
Invested Capital Turnover
1.88 1.93 1.78 1.56 1.40 1.49 1.46 1.18 1.06 1.11
Increase / (Decrease) in Invested Capital
25 13 111 121 51 0.11 378 716 -31 25
Enterprise Value (EV)
1,664 2,380 1,990 2,876 2,423 2,773 3,546 3,327 3,256 4,483
Market Capitalization
1,742 2,529 2,062 2,920 2,462 2,892 3,365 2,541 2,626 3,954
Book Value per Share
$14.59 $17.38 $18.82 $22.02 $23.60 $26.44 $29.49 $33.19 $37.10 $42.38
Tangible Book Value per Share
$13.75 $16.52 $16.21 $19.06 $20.68 $22.84 $17.60 $8.82 $13.43 $18.76
Total Capital
518 602 635 728 803 891 1,172 1,875 1,835 1,880
Total Debt
0.00 0.00 0.00 0.00 30 37 239 833 667 587
Total Long-Term Debt
0.00 0.00 0.00 0.00 30 37 0.00 581 559 545
Net Debt
-79 -149 -72 -43 -39 -118 181 787 630 530
Capital Expenditures (CapEx)
22 20 24 26 30 15 20 38 44 39
Debt-free, Cash-free Net Working Capital (DFCFNWC)
301 299 350 445 466 445 592 797 758 791
Debt-free Net Working Capital (DFNWC)
380 448 422 488 534 600 651 843 795 848
Net Working Capital (NWC)
380 448 422 488 534 600 412 591 687 806
Net Nonoperating Expense (NNE)
0.14 0.15 -0.21 0.01 0.02 -1.86 1.38 12 35 27
Net Nonoperating Obligations (NNO)
-79 -149 -72 -43 -39 -118 181 787 630 530
Total Depreciation and Amortization (D&A)
16 19 22 28 26 32 35 45 55 57
Debt-free, Cash-free Net Working Capital to Revenue
37.54% 34.74% 38.79% 45.67% 46.98% 40.70% 44.02% 45.95% 39.29% 39.36%
Debt-free Net Working Capital to Revenue
47.33% 52.09% 46.73% 50.13% 53.88% 54.93% 48.38% 48.61% 41.19% 42.21%
Net Working Capital to Revenue
47.33% 52.09% 46.73% 50.13% 53.88% 54.93% 30.59% 34.08% 35.58% 40.11%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$2.60 $3.07 $3.14 $4.04 $2.57 $3.31 $4.13 $3.87 $4.11 $6.17
Adjusted Weighted Average Basic Shares Outstanding
35.47M 34.52M 33.96M 33.10M 32.61M 32.28M 31.81M 31.43M 31.46M 30.80M
Adjusted Diluted Earnings per Share
$2.60 $3.07 $3.13 $4.02 $2.56 $3.30 $4.12 $3.85 $4.10 $6.14
Adjusted Weighted Average Diluted Shares Outstanding
35.54M 34.60M 34.05M 33.21M 32.69M 32.37M 31.96M 31.54M 31.53M 30.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
34.78M 34.55M 33.57M 32.99M 32.55M 32.18M 31.55M 31.45M 31.09M 30.58M
Normalized Net Operating Profit after Tax (NOPAT)
92 106 106 134 84 105 133 133 165 217
Normalized NOPAT Margin
11.52% 12.35% 11.78% 13.72% 8.45% 9.61% 9.88% 7.68% 8.54% 10.81%
Pre Tax Income Margin
18.18% 19.59% 19.55% 17.58% 10.67% 12.42% 12.62% 9.01% 8.73% 12.75%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 459.04 227.60 79.52 11.02 4.51 7.45
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 362.68 175.31 61.48 8.54 3.43 5.47
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 331.07 201.81 70.35 8.59 3.59 6.46
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 234.71 149.52 52.30 6.11 2.51 4.47
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 23.27% 71.42% 33.95% 49.35% 0.00% 47.63% 16.40% 12.15% 42.53%

Quarterly Metrics and Ratios for Dorman Products

This table displays calculated financial ratios and metrics derived from Dorman Products' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
18.67% 25.89% 16.23% 15.13% 18.07% -1.39% 0.42% 4.66% 3.19% 7.99%
EBITDA Growth
2.28% -15.31% -43.38% 16.13% 46.80% 95.28% 113.20% 25.96% 21.71% 11.09%
EBIT Growth
-5.09% -26.07% -60.53% 12.13% 54.20% 132.75% 194.50% 30.57% 24.80% 13.41%
NOPAT Growth
-3.37% -27.21% -56.24% 7.64% 52.40% 129.66% 158.38% 30.98% 24.49% 2.34%
Net Income Growth
-7.56% -47.66% -83.86% -13.55% 32.42% 181.92% 477.65% 44.68% 36.35% 8.41%
EPS Growth
-6.73% -46.73% -83.78% -13.33% 31.96% 180.70% 483.33% 47.12% 40.63% 10.00%
Operating Cash Flow Growth
-120.88% -45.71% 12.91% 370.48% 799.13% 383.21% 98.32% -4.99% -21.22% 19.74%
Free Cash Flow Firm Growth
72.08% -101.13% -33.69% -12.92% -282.20% 112.95% 111.46% 112.75% 108.73% -60.74%
Invested Capital Growth
13.04% 64.30% 48.65% 43.21% 38.33% -1.69% -1.41% -0.49% 1.25% 1.38%
Revenue Q/Q Growth
-0.95% 21.24% -6.89% 2.96% 1.59% 1.25% -5.18% 7.31% 0.16% 5.95%
EBITDA Q/Q Growth
-9.88% -12.40% -31.78% 115.62% 13.92% 16.53% -25.52% 27.39% 10.07% 6.37%
EBIT Q/Q Growth
-15.22% -20.59% -44.66% 200.98% 16.58% 19.86% -29.98% 33.44% 11.43% 8.93%
NOPAT Q/Q Growth
-16.89% -21.48% -38.03% 166.17% 17.67% 18.32% -30.28% 34.92% 11.85% -2.73%
Net Income Q/Q Growth
-19.27% -41.71% -68.14% 476.63% 23.66% 24.09% -34.71% 44.42% 16.54% -1.34%
EPS Q/Q Growth
-19.17% -41.24% -68.42% 477.78% 23.08% 25.00% -34.38% 45.71% 17.65% -2.22%
Operating Cash Flow Q/Q Growth
-156.75% 253.49% 112.33% 154.39% -15.68% 6.09% -12.86% 21.87% -30.08% 61.26%
Free Cash Flow Firm Q/Q Growth
73.53% -488.33% 16.01% 13.65% 10.42% 119.93% -25.67% -3.95% -38.66% -10.35%
Invested Capital Q/Q Growth
3.44% 40.82% -0.51% -1.17% -0.09% 0.08% -0.23% -0.25% 1.65% 0.21%
Profitability Metrics
- - - - - - - - - -
Gross Margin
31.90% 31.47% 30.95% 34.02% 37.53% 39.29% 38.71% 39.65% 40.46% 41.54%
EBITDA Margin
12.95% 9.36% 6.86% 14.36% 16.11% 18.54% 14.56% 17.29% 19.00% 19.07%
Operating Margin
10.18% 6.54% 3.88% 11.49% 13.15% 15.63% 11.61% 14.41% 15.74% 16.25%
EBIT Margin
10.17% 6.66% 3.96% 11.57% 13.28% 15.72% 11.61% 14.43% 16.06% 16.51%
Profit (Net Income) Margin
7.40% 3.56% 1.22% 6.82% 8.30% 10.17% 7.00% 9.43% 10.97% 10.21%
Tax Burden Percent
77.10% 77.77% 87.19% 76.16% 77.04% 75.78% 74.96% 75.99% 77.69% 69.05%
Interest Burden Percent
94.42% 68.72% 35.29% 77.40% 81.15% 85.42% 80.50% 85.95% 87.93% 89.61%
Effective Tax Rate
22.90% 22.23% 12.81% 23.84% 22.96% 24.22% 25.04% 24.01% 22.31% 30.95%
Return on Invested Capital (ROIC)
10.46% 5.99% 4.00% 10.67% 12.68% 12.60% 9.31% 11.92% 13.32% 12.45%
ROIC Less NNEP Spread (ROIC-NNEP)
9.75% 4.41% 2.05% 8.77% 10.79% 11.43% 8.16% 10.75% 12.31% 11.52%
Return on Net Nonoperating Assets (RNNOA)
2.65% 2.16% 1.06% 4.13% 4.75% 7.33% 5.10% 6.11% 6.53% 5.43%
Return on Equity (ROE)
13.10% 8.15% 5.05% 14.79% 17.43% 19.93% 14.41% 18.04% 19.85% 17.88%
Cash Return on Invested Capital (CROIC)
-0.59% -39.61% -31.78% -28.02% -23.65% 10.79% 11.98% 11.85% 10.71% 10.63%
Operating Return on Assets (OROA)
9.70% 5.75% 3.57% 10.72% 12.66% 13.09% 10.01% 12.42% 13.68% 14.06%
Return on Assets (ROA)
7.06% 3.07% 1.10% 6.32% 7.92% 8.47% 6.04% 8.11% 9.34% 8.70%
Return on Common Equity (ROCE)
13.10% 8.15% 5.05% 14.79% 17.43% 19.93% 14.41% 18.04% 19.85% 17.88%
Return on Equity Simple (ROE_SIMPLE)
13.50% 0.00% 8.77% 8.00% 8.58% 0.00% 13.32% 14.24% 15.05% 0.00%
Net Operating Profit after Tax (NOPAT)
32 25 16 42 49 59 41 55 62 60
NOPAT Margin
7.85% 5.08% 3.38% 8.75% 10.13% 11.84% 8.71% 10.95% 12.22% 11.22%
Net Nonoperating Expense Percent (NNEP)
0.71% 1.58% 1.95% 1.90% 1.89% 1.16% 1.15% 1.18% 1.01% 0.93%
Return On Investment Capital (ROIC_SIMPLE)
- 1.36% - - - 3.19% - - - 3.19%
Cost of Revenue to Revenue
68.10% 68.53% 69.05% 65.98% 62.47% 60.71% 61.29% 60.35% 59.54% 58.46%
SG&A Expenses to Revenue
21.72% 24.94% 27.07% 22.54% 24.38% 23.67% 27.10% 25.24% 24.72% 25.28%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.72% 24.94% 27.07% 22.54% 24.38% 23.67% 27.10% 25.24% 24.72% 25.28%
Earnings before Interest and Taxes (EBIT)
42 33 18 56 65 78 54 73 81 88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
54 47 32 69 79 92 68 87 96 102
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.56 2.44 2.59 2.28 2.11 2.25 2.58 2.36 2.81 3.06
Price to Tangible Book Value (P/TBV)
3.98 9.17 9.39 7.53 6.31 6.21 6.97 6.06 6.85 6.91
Price to Revenue (P/Rev)
1.60 1.47 1.51 1.33 1.23 1.36 1.57 1.45 1.76 1.97
Price to Earnings (P/E)
19.44 21.23 30.05 28.94 24.71 20.21 19.47 16.74 18.66 21.28
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.14% 4.71% 3.33% 3.46% 4.05% 4.95% 5.14% 5.97% 5.36% 4.70%
Enterprise Value to Invested Capital (EV/IC)
2.22 1.82 1.91 1.78 1.70 1.81 2.04 1.91 2.23 2.46
Enterprise Value to Revenue (EV/Rev)
1.77 1.92 1.94 1.71 1.58 1.69 1.89 1.75 2.06 2.23
Enterprise Value to EBITDA (EV/EBITDA)
12.84 15.37 18.15 15.85 13.48 12.00 11.88 10.53 11.85 12.71
Enterprise Value to EBIT (EV/EBIT)
15.73 19.37 24.28 21.36 17.73 15.04 14.48 12.71 14.21 15.15
Enterprise Value to NOPAT (EV/NOPAT)
20.24 25.00 31.13 27.82 23.17 19.77 19.15 16.80 18.78 20.64
Enterprise Value to Operating Cash Flow (EV/OCF)
55.44 79.82 77.95 32.85 18.92 15.60 15.58 14.82 18.50 19.40
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 16.65 16.88 16.11 20.95 23.30
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.31 0.80 0.77 0.69 0.62 0.57 0.56 0.53 0.51 0.45
Long-Term Debt to Equity
0.08 0.56 0.55 0.52 0.50 0.48 0.48 0.46 0.44 0.42
Financial Leverage
0.27 0.49 0.52 0.47 0.44 0.64 0.63 0.57 0.53 0.47
Leverage Ratio
1.77 2.03 1.98 1.93 1.89 2.10 2.02 1.99 1.96 1.92
Compound Leverage Factor
1.68 1.40 0.70 1.50 1.53 1.79 1.62 1.71 1.72 1.72
Debt to Total Capital
23.48% 44.40% 43.38% 40.79% 38.32% 36.34% 35.77% 34.61% 33.78% 31.21%
Short-Term Debt to Total Capital
17.19% 13.43% 12.30% 9.76% 7.23% 5.91% 5.12% 4.63% 4.32% 2.24%
Long-Term Debt to Total Capital
6.29% 30.97% 31.08% 31.02% 31.09% 30.43% 30.65% 29.98% 29.46% 28.97%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
76.52% 55.60% 56.62% 59.21% 61.68% 63.66% 64.23% 65.39% 66.22% 68.79%
Debt to EBITDA
1.39 3.85 4.19 3.71 3.09 2.46 2.13 1.95 1.84 1.66
Net Debt to EBITDA
1.24 3.63 4.02 3.54 2.95 2.32 2.02 1.81 1.71 1.50
Long-Term Debt to EBITDA
0.37 2.68 3.00 2.82 2.51 2.06 1.82 1.69 1.60 1.54
Debt to NOPAT
2.20 6.25 7.19 6.52 5.32 4.05 3.43 3.12 2.91 2.70
Net Debt to NOPAT
1.95 5.91 6.89 6.21 5.07 3.82 3.25 2.89 2.71 2.44
Long-Term Debt to NOPAT
0.59 4.36 5.15 4.96 4.31 3.39 2.94 2.70 2.54 2.51
Altman Z-Score
4.05 2.84 3.07 3.12 3.21 3.37 3.75 3.58 3.84 4.13
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.75 1.87 1.96 2.08 2.24 2.25 2.50 2.40 2.34 2.43
Quick Ratio
0.70 0.70 0.76 0.86 0.97 1.03 1.12 1.12 1.10 1.12
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-117 -690 -580 -501 -448 89 66 64 39 35
Operating Cash Flow to CapEx
-104.71% 87.53% 248.74% 523.69% 581.61% 540.68% 483.31% 530.78% 517.74% 873.59%
Free Cash Flow to Firm to Interest Expense
-50.06 -66.11 -48.51 -39.85 -36.72 7.89 6.27 6.26 4.01 3.83
Operating Cash Flow to Interest Expense
-3.43 1.18 2.19 5.31 4.60 5.27 4.90 6.21 4.54 7.80
Operating Cash Flow Less CapEx to Interest Expense
-6.71 -0.17 1.31 4.29 3.81 4.29 3.89 5.04 3.66 6.91
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.95 0.86 0.90 0.93 0.95 0.83 0.86 0.86 0.85 0.85
Accounts Receivable Turnover
3.64 3.85 4.06 4.28 4.22 4.04 4.22 3.99 3.73 3.65
Inventory Turnover
1.89 1.82 1.95 1.98 1.98 1.79 1.85 1.89 1.85 1.79
Fixed Asset Turnover
13.68 13.17 13.44 13.57 13.84 12.51 12.30 12.13 12.18 12.38
Accounts Payable Turnover
6.26 6.55 7.85 7.11 7.20 6.98 8.73 7.55 6.54 5.89
Days Sales Outstanding (DSO)
100.32 94.75 89.82 85.26 86.47 90.24 86.51 91.41 97.79 99.97
Days Inventory Outstanding (DIO)
192.66 201.01 186.82 184.39 184.72 204.34 197.22 192.76 197.82 204.12
Days Payable Outstanding (DPO)
58.31 55.75 46.48 51.32 50.68 52.28 41.83 48.34 55.83 61.98
Cash Conversion Cycle (CCC)
234.66 240.01 230.16 218.33 220.52 242.30 241.90 235.83 239.78 242.12
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,299 1,829 1,820 1,799 1,797 1,798 1,794 1,790 1,819 1,823
Invested Capital Turnover
1.33 1.18 1.18 1.22 1.25 1.06 1.07 1.09 1.09 1.11
Increase / (Decrease) in Invested Capital
150 716 596 543 498 -31 -26 -8.77 22 25
Enterprise Value (EV)
2,887 3,327 3,483 3,193 3,054 3,256 3,655 3,425 4,057 4,483
Market Capitalization
2,609 2,541 2,713 2,481 2,386 2,626 3,035 2,837 3,472 3,954
Book Value per Share
$32.48 $33.19 $33.36 $34.51 $35.83 $37.10 $37.72 $38.74 $40.38 $42.38
Tangible Book Value per Share
$20.88 $8.82 $9.18 $10.47 $12.01 $13.43 $13.98 $15.09 $16.59 $18.76
Total Capital
1,334 1,875 1,853 1,834 1,829 1,835 1,829 1,837 1,864 1,880
Total Debt
313 833 804 748 701 667 654 636 630 587
Total Long-Term Debt
84 581 576 569 569 559 560 551 549 545
Net Debt
278 787 771 712 669 630 620 588 585 530
Capital Expenditures (CapEx)
7.68 14 11 13 9.67 11 11 12 8.56 8.18
Debt-free, Cash-free Net Working Capital (DFCFNWC)
697 797 777 762 763 758 756 757 790 791
Debt-free Net Working Capital (DFNWC)
733 843 811 797 794 795 791 804 835 848
Net Working Capital (NWC)
503 591 583 618 662 687 697 719 755 806
Net Nonoperating Expense (NNE)
1.86 7.65 10 9.27 8.94 8.25 7.98 7.65 6.33 5.39
Net Nonoperating Obligations (NNO)
278 787 771 712 669 630 620 588 585 530
Total Depreciation and Amortization (D&A)
12 14 14 13 14 14 14 14 15 14
Debt-free, Cash-free Net Working Capital to Revenue
42.75% 45.95% 43.22% 40.91% 39.37% 39.29% 39.16% 38.71% 40.11% 39.36%
Debt-free Net Working Capital to Revenue
44.92% 48.61% 45.07% 42.83% 41.02% 41.19% 40.94% 41.14% 42.41% 42.21%
Net Working Capital to Revenue
30.86% 34.08% 32.40% 33.21% 34.20% 35.58% 36.09% 36.79% 38.32% 40.11%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.97 $0.57 $0.18 $1.04 $1.29 $1.60 $1.05 $1.53 $1.81 $1.78
Adjusted Weighted Average Basic Shares Outstanding
31.41M 31.43M 31.44M 31.47M 31.48M 31.46M 31.14M 30.96M 30.57M 30.80M
Adjusted Diluted Earnings per Share
$0.97 $0.57 $0.18 $1.04 $1.28 $1.60 $1.05 $1.53 $1.80 $1.76
Adjusted Weighted Average Diluted Shares Outstanding
31.55M 31.54M 31.54M 31.53M 31.56M 31.53M 31.25M 31.07M 30.74M 30.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
31.42M 31.45M 31.47M 31.49M 31.49M 31.09M 31.01M 30.57M 30.52M 30.58M
Normalized Net Operating Profit after Tax (NOPAT)
32 25 16 42 49 59 41 55 62 60
Normalized NOPAT Margin
7.85% 5.08% 3.38% 8.75% 10.13% 11.84% 8.71% 10.95% 12.22% 11.22%
Pre Tax Income Margin
9.60% 4.58% 1.40% 8.95% 10.77% 13.42% 9.34% 12.40% 14.12% 14.79%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
17.93 3.20 1.55 4.42 5.31 6.86 5.13 7.12 8.29 9.62
NOPAT to Interest Expense
13.85 2.44 1.32 3.35 4.05 5.17 3.85 5.40 6.31 6.54
EBIT Less CapEx to Interest Expense
14.66 1.85 0.66 3.41 4.51 5.88 4.12 5.95 7.41 8.73
NOPAT Less CapEx to Interest Expense
10.57 1.09 0.44 2.33 3.26 4.19 2.83 4.23 5.43 5.65
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 16.40% 0.00% 0.00% 0.00% 12.15% 27.42% 39.12% 50.93% 42.53%

Frequently Asked Questions About Dorman Products' Financials

When does Dorman Products's fiscal year end?

According to the most recent income statement we have on file, Dorman Products' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Dorman Products' net income changed over the last 9 years?

Dorman Products' net income appears to be on an upward trend, with a most recent value of $190.00 million in 2024, rising from $92.33 million in 2015. The previous period was $129.26 million in 2023.

What is Dorman Products's operating income?
Dorman Products's total operating income in 2024 was $292.91 million, based on the following breakdown:
  • Total Gross Profit: $806.36 million
  • Total Operating Expenses: $513.45 million
How has Dorman Products revenue changed over the last 9 years?

Over the last 9 years, Dorman Products' total revenue changed from $802.96 million in 2015 to $2.01 billion in 2024, a change of 150.2%.

How much debt does Dorman Products have?

Dorman Products' total liabilities were at $1.13 billion at the end of 2024, a 0.6% increase from 2023, and a 989.3% increase since 2015.

How much cash does Dorman Products have?

In the past 9 years, Dorman Products' cash and equivalents has ranged from $36.81 million in 2023 to $155.58 million in 2020, and is currently $57.14 million as of their latest financial filing in 2024.

How has Dorman Products' book value per share changed over the last 9 years?

Over the last 9 years, Dorman Products' book value per share changed from 14.59 in 2015 to 42.38 in 2024, a change of 190.4%.



This page (NASDAQ:DORM) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners